Percutaneous interventions in patients with coronary artery disease and specific clinical conditions

November 09, 2022 | | USA

Percutaneous_interven_tions
After watching this webinar, participants will understand: indications for percutaneous treatment of cardiogenic shock; evidence and limitations for interventional CAD treatment of diabetic patients; diagnostic and therapeutic approaches to CAD in patients with advanced kidney disease; and indications and strategies for performing CHIP.
Register Now

Spotlight

Following a remarkable run of 19 years of consecutive yearly growth from 1996 to 2014, the annual global hectarage of biotech crops peaked at 181.5 million in 2014, compared with 179.7 million hectares in 2015, equivalent to a net marginal year-to-year decrease of 1.0% between 2014 and 2015. Some countries increased their total plantings, whilst others reduced their hectarage principally due to the current low prices of commodity crops; these hectarage decreases are likely to revert to higher hectarage levels when crop prices improve.

OTHER LIVE WEBINARS

Medical Tech-BioTech Day

December 07, 2022 | 10:00 AM CET

The medical technology industry becomes an essentiel component of the whole care pathway. Advanced technologies such as Smart connectivity, Health Sensors, AI/ML in decision making, robotics, VR/AR/XR are not only improving medical devices but also are opening new perspectives for the care of human beings. According to « Absolute Markets Insights ». Global medical technology market was valued at US$ 565,52 billion in 2018 and is expected to reach 2324.34 billion by 2027, growing at an estimated CAGR of 17.1% over the forecast period. The segments that we will develop in this conference are about the use of solutions in the field of of mHealth, eHealth, telemedicine, telematics / telemetry, medical information systems / software, Medical Apps, portable diagnostics, wearables and augmenting human features and well beings.
Register Now

Cardiovascular Regenerative Medicine: Deconstructing Regenerative Therapeutics

October 12, 2022 | 8:00 AM PT

Dr. Marbán’s lab has found several noncoding RNA (ncRNA) species, including short Y RNAs, which themselves have intriguing biological actions. The ncRNA within extracellular vesicles can either be used as they occur naturally or serve as bioinspiration for new chemical entities. The next generations of cell-free biologics (extracellular vesicles and noncoding RNAs) may provide, or even transcend, the benefits of cell therapy without the intrinsic limitations.
Register Now

Diagnostic strategies in patients with acute hypotension

November 08, 2022 | 6:00 PM CET

After watching this webinar, participants will be able to: identify diagnostic strategies in patients with acute arterial systemic hypotension; distinguish life-threatening from non-life-threatening causes of acute hypotension; and rapidly identify treatment strategies based on presumed diagnoses.
Register Now

The Next Step in Evolution of Real-Time Live-Cell Analysis

August 23, 2022 | 1:00PM EST

Utilizing a multiplexed real-time cellular analysis approach empowers researchers to gain deeper insights into immune cell-killing, cell migration and invasion, cytotoxicity, 3D tumor spheroids, anti-viral assays and many more which we will cover in detail in this webinar.
Register Now

Spotlight

Following a remarkable run of 19 years of consecutive yearly growth from 1996 to 2014, the annual global hectarage of biotech crops peaked at 181.5 million in 2014, compared with 179.7 million hectares in 2015, equivalent to a net marginal year-to-year decrease of 1.0% between 2014 and 2015. Some countries increased their total plantings, whilst others reduced their hectarage principally due to the current low prices of commodity crops; these hectarage decreases are likely to revert to higher hectarage levels when crop prices improve.

resources